Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102048137 | 10204813 | 7 | F | 20060903 | 20160902 | 20140529 | 20160908 | EXP | US-009507513-1405USA011583 | MERCK | 0.00 | F | Y | 0.00000 | 20160908 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102048137 | 10204813 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNKNOWN | 20560 | 70 | MG | TABLET | |||||||
| 102048137 | 10204813 | 2 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | 70 MG, UNKNOWN | 0 | 70 | MG | TABLET | |||||||
| 102048137 | 10204813 | 3 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | U | 20560 | 70 | MG | TABLET | ||||||
| 102048137 | 10204813 | 4 | C | HORMONES (UNSPECIFIED) | UNSPECIFIED INGREDIENT | 1 | UNK | U | 0 | ||||||||||
| 102048137 | 10204813 | 5 | C | ONE-A-DAY ESSENTIAL VITAMINS | 2 | UNK | U | 0 | |||||||||||
| 102048137 | 10204813 | 6 | C | CALCIUM (UNSPECIFIED) | CALCIUM | 1 | 1200-1500 IU, UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102048137 | 10204813 | 1 | Osteoporosis |
| 102048137 | 10204813 | 2 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102048137 | 10204813 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102048137 | 10204813 | Adverse event | |
| 102048137 | 10204813 | Dyspepsia | |
| 102048137 | 10204813 | Femur fracture | |
| 102048137 | 10204813 | Gait disturbance | |
| 102048137 | 10204813 | General physical health deterioration | |
| 102048137 | 10204813 | Nasal congestion | |
| 102048137 | 10204813 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102048137 | 10204813 | 1 | 20020923 | 200702 | 0 | |
| 102048137 | 10204813 | 2 | 20070303 | 20090219 | 0 | |
| 102048137 | 10204813 | 3 | 20090318 | 20120602 | 0 | |
| 102048137 | 10204813 | 4 | 20020114 | 20101130 | 0 | |
| 102048137 | 10204813 | 5 | 2002 | 0 | ||
| 102048137 | 10204813 | 6 | 2002 | 0 |